Virtify Simplifies PIM Labeling with New Software Release
Virtify, Inc. today announced the upcoming release of its new software product Virtify PIM Enterprise, part of the Virtify Enterprise Content Compliance (ECC) Software Suite. Virtify PIM is designed to help companies stay compliant with the new EU labeling standard, and is a Web-based product that enables the creation of PIM submissions in a collaborative, "best-practices" environment.
The PIM standard is being implemented to enable the efficient exchange and evaluation of product information for obtaining marketing authorization in Europe. A key goal is to reduce the repetition of content across multiple countries and documents through a single, centralized XML submission. Moreover, electronic authoring and publishing for PIM XML must integrate with existing translation processes and software.
Virtify PIM Enterprise is a software solution designed to enable customers to comply with the PIM standard for submitting product label information in an efficient, consistent and predictable manner. Virtify PIM's structured content approach allows users to operate at the PIM element and PIM fragment level-the same content levels specified by the PIM standard. This capability provides users with unprecedented content control and flexibility, allowing authors and reviewers to "parallel-process" different sections of the PIM submission or submissions. In addition, the software has a rapid deployment and implementation cycle and is not dependent on any third party infrastructure or solution.
The PIM standard is currently in pilot. It is expected to move into production in 2011 for new approvals using the centralized procedure. A full migration of legacy product information will be required in the future.
Virtify PIM is built upon Virtify's structured content management engine. Key capabilities include:
* Comprehensive PIM Lifecycle Management with integrated workflow for rapid status and centralized management of PIM submissions including content creation, review, approval, and translations, as well as bi-directional communication and comments from EMA
* Role-based, granular access control at the PIM document, PIM element, PIM fragment, and language level.
* Automated XML generation with no programming knowledge required
* Integrated Translation Management through standard web services for translation tracking and status reporting through the Virtify PIM dashboard
Virtify is currently exhibiting at the 2nd Successful eCTD Lifecycle Management Conference in Prague, Czech Republic. Virtify PIM Enterprise will be available to customers in October 2010.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
